drugset / Trial / NCT01461460
A Thorough QT Study of TR-701free Acid (FA) in Healthy Subjects
RandomizedCrossoverDouble-blindOther
Summary
The purpose of this study is to assess the effects of oral TR-701 free acid (FA) versus placebo on QTcF.
Timeline
- Start
- 2011-11-28
- Primary completion
- 2011-12-23
- Completion
- 2011-12-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Moxifloxacin | Small molecule | 400 mg | — |
| Subject | Tedizolid | Small molecule | 200 mg | Oral |
| Subject | Tedizolid | Small molecule | 1200 mg | Oral |
Indications
No indication recorded.